Analysts have great faith in incoming Ambu CEO

Britt Meelby Jensen, who was appointed the new chief executive of Ambu yesterday, is the obvious candidate to rebuild trust in the medtech firm after years of downgrades, say analysts.
Photo: PR / Ambu
Photo: PR / Ambu
by christopher due karlsson, translated by daniel pedersen

Britt Meelby Jensen, who was appointed the next CEO of Ambu on Thursday, is the right person for the job of reestablishing faith in the medtech company, which has disappointed analysts with seven downgrades since 2019, say a number of analysts according to Danish media Finans.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading

Ambu still has products in Russia but is attempting to exit the market | Foto: Dmitry Serebryakov/AP/Ritzau Scanpix

Ambu opens up about stalled Russian exit

For subscribers